Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Zachary Zimmerman

Premium

Arcturus Therapeutics has named Zachary Zimmerman as its chief business officer.

Zimmerman will be in charge of the company's corporate strategy, business development activities, and strategic relationships. He previously served as senior director of corporate development for Regulus Therapeutics and director of business development for Alnylam Pharmaceuticals.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.